SHERYL HORWITZ: Open Payments
NPI 1043303902 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 13 payments from 11 companies in 2025. Trend: 2023 $442 · 2024 $280 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $95 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Exeltis, USA Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $28 |
| Lilly USA, LLC | 1 | $23 |
| Organon LLC | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: DUPIXENT, XIFAXAN, SLYND, Ozempic, ZEPBOUND, NEXPLANON, MYFEMBREE, Cologuard Collection Kit.
Industry payments across OR — which companies pay providers there.
